Virtu Financial LLC Aclaris Therapeutics, Inc. Transaction History

Virtu Financial LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 09, 2024	BUY	$1.01 - $1.36 $11,738 - $15,805	11,622 New	11,622 $13,000
Q1 2021 May 19, 2021	SELL	$5.86 - $27.73 $127,812 - $604,819	-21,811 Closed	0 $0
Q4 2020 Feb 24, 2021	BUY	$2.65 - $7.61 $57,799 - $165,981	21,811 New	21,811 $141,000
Q3 2020 Dec 11, 2020	SELL	$1.5 - $2.71 $56,170 - $101,481	-37,447 Closed	0 $0
Q2 2020 Aug 07, 2020	SELL	$1.04 - $1.73 $1,313 - $2,184	-1,263 Reduced 3.26%	37,447 $61,000
Q4 2019 Feb 04, 2020	SELL	$1.02 - $1.97 $15,780 - $30,477	-15,471 Reduced 28.55%	38,710 $73,000
Q3 2019 Nov 20, 2019	SELL	$0.79 - $2.47 $23,192 - $72,514	-29,358 Reduced 35.14%	54,181 $59,000
Q2 2019 Aug 13, 2019	BUY	$2.13 - $7.06 $152,893 - $506,773	71,781 Added 610.49%	83,539 $183,000
Q1 2019 Apr 12, 2019	BUY	$5.63 - $7.84 $66,197 - $92,182	11,758 New	11,758 $70,000

50.7M

30.6K

Ticker ACRS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 66,671,800
Market Cap $253M
Description
Aclaris Therapeutics, Inc. operates a clinical-stage biopharmaceutical company, develops novel drug candidates for immune-inflammatory diseases in the United States. It operates through two segments: Therapeutics and Contract Research. The Therapeutics segment is involved in identifying and developing innovative therapies to address significant ...

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Virtu Financial LLC with notifications on news.